부산대학교 도서관

Tummino TA; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, 94158, USA.; Graduate Program in Pharmaceutical Sciences and Pharmacogenomics, University of California, San Francisco, San Francisco, CA, 94158, USA.; Iliopoulos-Tsoutsouvas C; Center for Drug Discovery and Department of Pharmaceutical Sciences, Northeastern University, Boston, MA, 02115, USA.; Braz JM; Department of Anatomy, University of California, San Francisco, San Francisco, CA, 94158, USA.; O'Brien ES; Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, 94305, USA.; Stein RM; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, 94158, USA.; Graduate Program in Pharmaceutical Sciences and Pharmacogenomics, University of California, San Francisco, San Francisco, CA, 94158, USA.; Craik V; Department of Anatomy, University of California, San Francisco, San Francisco, CA, 94158, USA.; Tran NK; Center for Drug Discovery and Department of Pharmaceutical Sciences, Northeastern University, Boston, MA, 02115, USA.; Ganapathy S; Center for Drug Discovery and Department of Pharmaceutical Sciences, Northeastern University, Boston, MA, 02115, USA.; Liu F; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, 94158, USA.; Shiimura Y; Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, 94305, USA.; Division of Molecular Genetics, Institute of Life Science, Kurume University, Fukuoka, Japan.; Tong F; Center for Drug Discovery and Department of Pharmaceutical Sciences, Northeastern University, Boston, MA, 02115, USA.; Ho TC; Center for Drug Discovery and Department of Pharmaceutical Sciences, Northeastern University, Boston, MA, 02115, USA.; Radchenko DS; Enamine Ltd., 67 Winston Churchill Street, Kyiv, 02094, Ukraine.; Moroz YS; Enamine Ltd., 67 Winston Churchill Street, Kyiv, 02094, Ukraine.; National Taras Shevchenko University of Kyiv, 60 Volodymyrska Stree, Kyiv, 01601, Ukraine.; Chemspace LLC, 85 Winston Churchill Street, Suite 1, Kyiv, 02094, Ukraine.; Rosado SR; Department of Anatomy, University of California, San Francisco, San Francisco, CA, 94158, USA.; Bhardwaj K; Department of Anatomy, University of California, San Francisco, San Francisco, CA, 94158, USA.; Benitez J; Department of Anatomy, University of California, San Francisco, San Francisco, CA, 94158, USA.; Liu Y; National Institute of Mental Health Psychoactive Drug Screening Program (NIMH PDSP), School of Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, 27599, USA.; Kandasamy H; Domain Therapeutics North America Inc., Montréal, Québec, H4S 1Z9, Canada.; Normand C; Domain Therapeutics North America Inc., Montréal, Québec, H4S 1Z9, Canada.; Semache M; Domain Therapeutics North America Inc., Montréal, Québec, H4S 1Z9, Canada.; Sabbagh L; Domain Therapeutics North America Inc., Montréal, Québec, H4S 1Z9, Canada.; Glenn I; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, 94158, USA.; Irwin JJ; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, 94158, USA.; Kumar KK; Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, 94305, USA. kaavyak@stanford.edu.; Makriyannis A; Center for Drug Discovery and Department of Pharmaceutical Sciences, Northeastern University, Boston, MA, 02115, USA. a.makriyannis@northeastern.edu.; Department of Chemistry and Chemical Biology, Northeastern University, Boston, MA, 02115, USA. a.makriyannis@northeastern.edu.; Basbaum AI; Department of Anatomy, University of California, San Francisco, San Francisco, CA, 94158, USA. allan.basbaum@ucsf.edu.; Shoichet BK; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, 94158, USA. bshoichet@gmail.com.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Jain MK; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7365, USA.; Gumpper RH; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7365, USA.; Slocum ST; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7365, USA.; Schmitz GP; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7365, USA.; Madsen JS; Department of Drug Design and Pharmacology, University of Copenhagen, 2100 Copenhagen, Denmark.; Tummino TA; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA 94158, USA.; Suomivuori CM; Department of Computer Science, Stanford University, Stanford, CA 94305, USA; Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA 94304, USA; Department of Structural Biology, Stanford University School of Medicine, Stanford, CA 94305, USA; Institute for Computational and Mathematical Engineering, Stanford University, Stanford, CA 94305, USA.; Huang XP; National Institute of Mental Health Psychoactive Drug Screening Program, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7365, USA.; Shub L; Institute of Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA 94158, USA.; DiBerto JF; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7365, USA.; Kim K; Department of System Biology, College of Life Science and Biotechnology, Yonsei University, Seoul 03722, South Korea.; DeLeon C; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7365, USA.; Krumm BE; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7365, USA.; Fay JF; Department of Biochemistry and Molecular Biology, School of Medicine, University of Maryland, Baltimore, MD 21201, USA.; Keiser M; Institute of Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA 94158, USA.; Hauser AS; Department of Drug Design and Pharmacology, University of Copenhagen, 2100 Copenhagen, Denmark.; Dror RO; Department of Computer Science, Stanford University, Stanford, CA 94305, USA; Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA 94304, USA; Department of Structural Biology, Stanford University School of Medicine, Stanford, CA 94305, USA; Institute for Computational and Mathematical Engineering, Stanford University, Stanford, CA 94305, USA.; Shoichet B; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA 94158, USA.; Gloriam DE; Department of Drug Design and Pharmacology, University of Copenhagen, 2100 Copenhagen, Denmark.; Nichols DE; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7365, USA.; Roth BL; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7365, USA; National Institute of Mental Health Psychoactive Drug Screening Program, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7365, USA; Divison of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7360, USA. Electronic address: bryan_roth@med.unc.edu.

Publisher: Cell Press Country of Publication: United States NLM ID: 8809320 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-4199 (Electronic) Linking ISSN: 08966273 NLM ISO Abbreviation: Neuron Subsets: MEDLINE

Lyu J; Department of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158, USA.; The Evnin Family Laboratory of Computational Molecular Discovery, The Rockefeller University, New York, NY 10065, USA.; Kapolka N; Department of Pharmacology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA.; Gumpper R; Department of Pharmacology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA.; Alon A; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA.; Wang L; Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA 94035, USA.; Jain MK; Department of Pharmacology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA.; Barros-Álvarez X; Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA 94035, USA.; Sakamoto K; Department of Pharmacology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA.; National Institute of Mental Health Psychoactive Drug Screening Program (NIMH PDSP), School of Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA.; Kim Y; Department of Pharmacology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA.; DiBerto J; Department of Pharmacology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA.; Kim K; Department of Pharmacology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA.; Glenn IS; Department of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158, USA.; Tummino TA; Department of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158, USA.; Huang S; Department of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158, USA.; Irwin JJ; Department of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158, USA.; Tarkhanova OO; Chemspace LLC, Kyiv 02094, Ukraine.; Moroz Y; Chemspace LLC, Kyiv 02094, Ukraine.; Taras Shevchenko National University of Kyiv, Kyiv 01601, Ukraine.; Enamine Ltd., Kyiv 02094, Ukraine.; Skiniotis G; Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA 94035, USA.; Department of Structural Biology, Stanford University School of Medicine, Stanford, CA 94304, USA.; Kruse AC; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA.; Shoichet BK; Department of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158, USA.; Roth BL; Department of Pharmacology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA.; National Institute of Mental Health Psychoactive Drug Screening Program (NIMH PDSP), School of Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA.; Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-9203 (Electronic) Linking ISSN: 00368075 NLM ISO Abbreviation: Science Subsets: MEDLINE

Hall BW; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California 94158, United States.; Tummino TA; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California 94158, United States.; Tang K; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California 94158, United States.; Mailhot O; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California 94158, United States.; Castanon M; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California 94158, United States.; Irwin JJ; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California 94158, United States.; Shoichet BK; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California 94158, United States.

Publisher: American Chemical Society Country of Publication: United States NLM ID: 101230060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-960X (Electronic) Linking ISSN: 15499596 NLM ISO Abbreviation: J Chem Inf Model Subsets: MEDLINE

Haas KM; J. David Gladstone Institutes, San Francisco, CA, 94158, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA.; McGregor MJ; J. David Gladstone Institutes, San Francisco, CA, 94158, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA.; Bouhaddou M; J. David Gladstone Institutes, San Francisco, CA, 94158, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA.; Polacco BJ; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA.; Kim EY; Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, IL, 60611, USA.; Nguyen TT; J. David Gladstone Institutes, San Francisco, CA, 94158, USA.; Newton BW; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, 94158, USA.; Urbanowski M; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Kim H; Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, IL, 60611, USA.; Williams MAP; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA.; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Rezelj VV; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA.; Institut Pasteur, Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Paris, France.; Hardy A; Institut Pasteur, Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Paris, France.; Fossati A; J. David Gladstone Institutes, San Francisco, CA, 94158, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA.; Stevenson EJ; J. David Gladstone Institutes, San Francisco, CA, 94158, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA.; Sukerman E; Division of Infectious Diseases, Oregon Health & Science University, Portland, OR, 97239, USA.; Kim T; Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, IL, 60611, USA.; Penugonda S; Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, IL, 60611, USA.; Moreno E; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Department of Infectious Diseases, Hospital Universitario Ramón y Cajal and IRYCIS, Madrid, Spain.; Centro de Investigación en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; Braberg H; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA.; Zhou Y; J. David Gladstone Institutes, San Francisco, CA, 94158, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA.; Metreveli G; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Harjai B; J. David Gladstone Institutes, San Francisco, CA, 94158, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA.; Tummino TA; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA.; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, 94158, USA.; Graduate Program in Pharmaceutical Sciences and Pharmacogenomics, University of California San Francisco, San Francisco, CA, 94158, USA.; Melnyk JE; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA.; Soucheray M; J. David Gladstone Institutes, San Francisco, CA, 94158, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA.; Batra J; J. David Gladstone Institutes, San Francisco, CA, 94158, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA.; Pache L; Infectious and Inflammatory Disease Center, Immunity and Pathogenesis Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, 92037, USA.; Martin-Sancho L; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, 92037, USA.; Department of Infectious Disease, Imperial College London, London, SW7 2BX, UK.; Carlson-Stevermer J; Synthego Corporation, Redwood City, CA, 94063, USA.; Serotiny Inc., South San Francisco, CA, 94080, USA.; Jureka AS; Molecular Virology and Vaccine Team, Immunology and Pathogenesis Branch, Influenza Division, National Center for Immunization & Respiratory Diseases, Centers for Disease Control & Prevention, Atlanta, GA, 30333, USA.; General Dynamics Information Technology, Federal Civilian Division, Atlanta, GA, 30329, USA.; Basler CF; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Shokat KM; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA.; Howard Hughes Medical Institute, Chevy Chase, MD, 20815, USA.; Shoichet BK; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA.; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, 94158, USA.; Shriver LP; Department of Chemistry, Washington University in St. Louis, St. Louis, MO, 63105, USA.; Center for Metabolomics and Isotope Tracing, Washington University in St. Louis, St. Louis, MO, 63105, USA.; Johnson JR; J. David Gladstone Institutes, San Francisco, CA, 94158, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, 94158, USA.; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Shaw ML; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Department of Medical Biosciences, University of the Western Cape, Bellville, 7535, Western Cape, South Africa.; Chanda SK; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, 92037, USA.; Roden DM; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.; Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.; Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.; Carter TC; Center for Precision Medicine Research, Marshfield Clinic Research Institute, Marshfield, WI, 54449, USA.; Kottyan LC; Center of Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA.; Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, 45229, USA.; Chisholm RL; Center for Genetic Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA.; Pacheco JA; Center for Genetic Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA.; Smith ME; Center for Genetic Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA.; Schrodi SJ; Laboratory of Genetics, School of Medicine and Public Health, University of Wisconsin Madison, Madison, WI, 53706, USA.; Albrecht RA; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Vignuzzi M; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA.; Institut Pasteur, Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Paris, France.; Zuliani-Alvarez L; J. David Gladstone Institutes, San Francisco, CA, 94158, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA.; Swaney DL; J. David Gladstone Institutes, San Francisco, CA, 94158, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA.; Eckhardt M; J. David Gladstone Institutes, San Francisco, CA, 94158, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA.; Wolinsky SM; Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, IL, 60611, USA.; White KM; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA.; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Hultquist JF; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA. judd.hultquist@northwestern.edu.; Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, IL, 60611, USA. judd.hultquist@northwestern.edu.; Center for Pathogen Genomics and Microbial Evolution, Northwestern University Havey Institute for Global Health, Chicago, IL, 60611, USA. judd.hultquist@northwestern.edu.; Kaake RM; J. David Gladstone Institutes, San Francisco, CA, 94158, USA. robyn.kaake@ucsf.edu.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, 94158, USA. robyn.kaake@ucsf.edu.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, 94158, USA. robyn.kaake@ucsf.edu.; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA. robyn.kaake@ucsf.edu.; García-Sastre A; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA. adolfo.garcia-sastre@mssm.edu.; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. adolfo.garcia-sastre@mssm.edu.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. adolfo.garcia-sastre@mssm.edu.; Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. adolfo.garcia-sastre@mssm.edu.; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. adolfo.garcia-sastre@mssm.edu.; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. adolfo.garcia-sastre@mssm.edu.; Krogan NJ; J. David Gladstone Institutes, San Francisco, CA, 94158, USA. nevan.krogan@ucsf.edu.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, 94158, USA. nevan.krogan@ucsf.edu.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, 94158, USA. nevan.krogan@ucsf.edu.; Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), San Francisco, CA, 94158, USA. nevan.krogan@ucsf.edu.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Tummino TA; Department of Pharmaceutical Chemistry, University of California San Francisco (UCSF), San Francisco, CA, USA.; Graduate Program in Pharmaceutical Sciences and Pharmacogenomics, UCSF, San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), UCSF, San Francisco, CA, USA.; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Rezelj VV; Institut Pasteur, Viral Populations and Pathogenesis Unit, CNRS UMR 3569, 75724 Paris, Cedex 15, France.; Fischer B; Novartis Institutes for BioMedical Research, Preclinical Safety, Basel, Switzerland.; Fischer A; Novartis Institutes for BioMedical Research, Preclinical Safety, Basel, Switzerland.; O'Meara MJ; Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA.; Monel B; Institut Pasteur, Virus and Immunity Unit, CNRS UMR 3569, 75724 Paris, Cedex 15, France.; Vallet T; Institut Pasteur, Viral Populations and Pathogenesis Unit, CNRS UMR 3569, 75724 Paris, Cedex 15, France.; White KM; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Zhang Z; Quantitative Biosciences Institute (QBI), UCSF, San Francisco, CA, USA.; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, UCSF, San Francisco, CA, USA.; Howard Hughes Medical Institute, UCSF, San Francisco, CA, USA.; Alon A; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.; Schadt H; Novartis Institutes for BioMedical Research, Preclinical Safety, Basel, Switzerland.; O'Donnell HR; Department of Pharmaceutical Chemistry, University of California San Francisco (UCSF), San Francisco, CA, USA.; Lyu J; Department of Pharmaceutical Chemistry, University of California San Francisco (UCSF), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), UCSF, San Francisco, CA, USA.; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Rosales R; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; McGovern BL; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Rathnasinghe R; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Jangra S; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Schotsaert M; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Galarneau JR; Novartis Institutes for BioMedical Research, Preclinical Safety, Cambridge, MA, USA.; Krogan NJ; Quantitative Biosciences Institute (QBI), UCSF, San Francisco, CA, USA.; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, UCSF, San Francisco, CA, USA.; Gladstone Institute of Data Science and Biotechnology, J. David Gladstone Institutes, San Francisco, CA, USA.; Urban L; Novartis Institutes for BioMedical Research, Preclinical Safety, Cambridge, MA, USA.; Shokat KM; Quantitative Biosciences Institute (QBI), UCSF, San Francisco, CA, USA.; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, UCSF, San Francisco, CA, USA.; Howard Hughes Medical Institute, UCSF, San Francisco, CA, USA.; Kruse AC; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.; García-Sastre A; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Schwartz O; Institut Pasteur, Virus and Immunity Unit, CNRS UMR 3569, 75724 Paris, Cedex 15, France.; Moretti F; Novartis Institutes for BioMedical Research, Preclinical Safety, Basel, Switzerland. bshoichet@gmail.com francois.pognan@novartis.com marco.vignuzzi@pasteur.fr francesca.moretti@novartis.com.; Vignuzzi M; Institut Pasteur, Viral Populations and Pathogenesis Unit, CNRS UMR 3569, 75724 Paris, Cedex 15, France. bshoichet@gmail.com francois.pognan@novartis.com marco.vignuzzi@pasteur.fr francesca.moretti@novartis.com.; Pognan F; Novartis Institutes for BioMedical Research, Preclinical Safety, Basel, Switzerland. bshoichet@gmail.com francois.pognan@novartis.com marco.vignuzzi@pasteur.fr francesca.moretti@novartis.com.; Shoichet BK; Department of Pharmaceutical Chemistry, University of California San Francisco (UCSF), San Francisco, CA, USA. bshoichet@gmail.com francois.pognan@novartis.com marco.vignuzzi@pasteur.fr francesca.moretti@novartis.com.; Quantitative Biosciences Institute (QBI), UCSF, San Francisco, CA, USA.; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-9203 (Electronic) Linking ISSN: 00368075 NLM ISO Abbreviation: Science Subsets: MEDLINE

Lyu J; Department of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158, USA.; The Evnin Family Laboratory of Computational Molecular Discovery, The Rockefeller University, New York, NY 10065, USA (present address).; Kapolka N; Department of Pharmacology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599-7365, USA.; Gumpper R; Department of Pharmacology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599-7365, USA.; Alon A; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.; Pharmacology Department, Yale School of Medicine, New Haven, CT 06510, USA (present address).; Wang L; Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA.; Jain MK; Department of Pharmacology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599-7365, USA.; Barros-Álvarez X; Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA.; Sakamoto K; Department of Pharmacology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599-7365, USA.; National Institute of Mental Health Psychoactive Drug Screening Program (NIMH PDSP), School of Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599-7365, USA.; Kim Y; Department of Pharmacology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599-7365, USA.; DiBerto J; Department of Pharmacology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599-7365, USA.; Kim K; Department of Pharmacology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599-7365, USA.; Department of Pharmacy, College of Pharmacy, Yonsei University, Incheon 21983, Korea (present address).; Tummino TA; Department of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158, USA.; Huang S; Department of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158, USA.; Irwin JJ; Department of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158, USA.; Tarkhanova OO; Chemspace LLC, Kyiv, 02094, Ukraine.; Moroz Y; Chemspace LLC, Kyiv, 02094, Ukraine.; Taras Shevchenko National University of Kyiv, Kyiv, 01601, Ukraine.; Enamine Ltd., Kyiv, 02094, Ukraine.; Skiniotis G; Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA.; Department of Structural Biology, Stanford University School of Medicine, Stanford, CA, US.; Kruse AC; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.; Shoichet BK; Department of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158, USA.; Roth BL; Department of Pharmacology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599-7365, USA.; National Institute of Mental Health Psychoactive Drug Screening Program (NIMH PDSP), School of Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599-7365, USA.; Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7360, USA.

Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

Tummino TA; Iliopoulos-Tsoutsouvas C; Braz JM; O'Brien ES; Stein RM; Craik V; Tran NK; Ganapathy S; Liu F; Shiimura Y; Tong F; Ho TC; Radchenko DS; Moroz YS; Rosado SR; Bhardwaj K; Benitez J; Liu Y; Kandasamy H; Normand C; Semache M; Sabbagh L; Glenn I; Irwin JJ; Kumar KK; Makriyannis A; Basbaum AI; Shoichet BK

Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

David E. Gordon; Joseph Hiatt; Mehdi Bouhaddou; Veronica V. Rezelj; Svenja Ulferts; Hannes Braberg; Alexander S. Jureka; Kirsten Obernier; Jeffrey Z. Guo; Jyoti Batra; Robyn M. Kaake; Andrew R. Weckstein; Tristan W. Owens; Meghna Gupta; Sergei Pourmal; Erron W. Titus; Merve Cakir; Margaret Soucheray; Michael McGregor; Zeynep Cakir; Gwendolyn Jang; Matthew J. O’Meara; Tia A. Tummino; Ziyang Zhang; Helene Foussard; Ajda Rojc; Yuan Zhou; Dmitry Kuchenov; Ruth Hüttenhain; Jiewei Xu; Manon Eckhardt; Danielle L. Swaney; Jacqueline M. Fabius; Manisha Ummadi; Beril Tutuncuoglu; Ujjwal Rathore; Maya Modak; Paige Haas; Kelsey M. Haas; Zun Zar Chi Naing; Ernst H. Pulido; Ying Shi; Inigo Barrio-Hernandez; Danish Memon; Eirini Petsalaki; Alistair Dunham; Miguel Correa Marrero; David Burke; Cassandra Koh; Thomas Vallet; Jesus A. Silvas; Caleigh M. Azumaya; Christian Billesbølle; Axel F. Brilot; Melody G. Campbell; Amy Diallo; Miles Sasha Dickinson; Devan Diwanji; Nadia Herrera; Nick Hoppe; Huong T. Kratochvil; Yanxin Liu; Gregory E. Merz; Michelle Moritz; Henry C. Nguyen; Carlos Nowotny; Cristina Puchades; Alexandrea N. Rizo; Ursula Schulze-Gahmen; Amber M. Smith; Ming Sun; Iris D. Young; Jianhua Zhao; Daniel Asarnow; Justin Biel; Alisa Bowen; Julian R. Braxton; Jen Chen; Cynthia M. Chio; Un Seng Chio; Ishan Deshpande; Loan Doan; Bryan Faust; Sebastian Flores; Mingliang Jin; Kate Kim; Victor L. Lam; Fei Li; Junrui Li; Yen-Li Li; Yang Li; Xi Liu; Megan Lo; Kyle E. Lopez; Arthur A. Melo; Frank R. Moss; Phuong Nguyen; Joana Paulino; Komal Ishwar Pawar; Jessica K. Peters; Thomas H. Pospiech; Maliheh Safari; Smriti Sangwan; Kaitlin Schaefer; Paul V. Thomas; Aye C. Thwin; Raphael Trenker; Eric Tse; Tsz Kin Martin Tsui; Feng Wang; Natalie Whitis; Zanlin Yu; Kaihua Zhang; Yang Zhang; Fengbo Zhou; Daniel Saltzberg; Anthony J. Hodder; Amber S. Shun-Shion; Daniel M. Williams; Kris M. White; Romel Rosales; Thomas Kehrer; Lisa Miorin; Elena Moreno; Arvind H. Patel; Suzannah Rihn; Mir M. Khalid; Albert Vallejo-Gracia; Parinaz Fozouni; Camille R. Simoneau; Theodore L. Roth; David Wu; Mohd Anisul Karim; Maya Ghoussaini; Ian Dunham; Francesco Berardi; Sebastian Weigang; Maxime Chazal; Jisoo Park; James Logue; Marisa McGrath; Stuart Weston; Robert Haupt; C. James Hastie; Matthew Elliott; Fiona Brown; Kerry A. Burness; Elaine Reid; Mark Dorward; Clare Johnson; Stuart G. Wilkinson; Anna Geyer; Daniel M. Giesel; Carla Baillie; Samantha Raggett; Hannah Leech; Rachel Toth; Nicola Goodman; Kathleen C. Keough; Abigail L. Lind; Reyna J. Klesh; Kafi R. Hemphill; Jared Carlson-Stevermer; Jennifer Oki; Kevin Holden; Travis Maures; Katherine S. Pollard; Andrej Sali; David A. Agard; Yifan Cheng; James S. Fraser; Adam Frost; Natalia Jura; Tanja Kortemme; Aashish Manglik; Daniel R. Southworth; Robert M. Stroud; Dario R. Alessi; Paul Davies; Matthew B. Frieman; Trey Ideker; Carmen Abate; Nolwenn Jouvenet; Georg Kochs; Brian Shoichet; Melanie Ott; Massimo Palmarini; Kevan M. Shokat; Adolfo García-Sastre; Jeremy A. Rassen; Robert Grosse; Oren S. Rosenberg; Kliment A. Verba; Christopher F. Basler; Marco Vignuzzi; Andrew A. Peden; Pedro Beltrao; Nevan J. Krogan; Donovan Trinidad; Joana Damas; Graham M. Hughes; Corrie A. Painter; Nicole S. Persky; Marco Corbo; Bodgan Kirilenko; Michael Hiller; Klaus-Peter Koepfli; Irene Kaplow; Morgan Wirthlin; Andreas R. Pfenning; Huabin Zhao; Diane P. Genereux; Ross Swofford; Abigail Lind; Oliver A. Ryderq; Martin T. Nweeia; Jennifer Meadows; Michael Dong; Ola Wallerman; Vikki Marinescu; Kerstin Lindblad-Toh; David A. Ray; Sarahjane Power; Emma C. Teeling; Gaurav Chauhan; Shirley Xue Li; Elinor K. Karlsson; Harris A. Lewin

Science
Science, vol 370, iss 6521

Gordon, David E; Jang, Gwendolyn M; Bouhaddou, Mehdi; Xu, Jiewei; Obernier, Kirsten; White, Kris M; O'Meara, Matthew J; Rezelj, Veronica V; Guo, Jeffrey Z; Swaney, Danielle L; Tummino, Tia A; Hüttenhain, Ruth; Kaake, Robyn M; Richards, Alicia L; Tutuncuoglu, Beril; Foussard, Helene; Batra, Jyoti; Haas, Kelsey; Modak, Maya; Kim, Minkyu; Haas, Paige; Polacco, Benjamin J; Braberg, Hannes; Fabius, Jacqueline M; Eckhardt, Manon; Soucheray, Margaret; Bennett, Melanie J; Cakir, Merve; McGregor, Michael J; Li, Qiongyu; et al

Jacobs B; Laboratory of Quantitative Neuromorphology, Neuroscience Program, Colorado College, Colorado Springs, Colorado.; Garcia ME; Laboratory of Quantitative Neuromorphology, Neuroscience Program, Colorado College, Colorado Springs, Colorado.; Shea-Shumsky NB; Laboratory of Quantitative Neuromorphology, Neuroscience Program, Colorado College, Colorado Springs, Colorado.; Tennison ME; Laboratory of Quantitative Neuromorphology, Neuroscience Program, Colorado College, Colorado Springs, Colorado.; Schall M; Laboratory of Quantitative Neuromorphology, Neuroscience Program, Colorado College, Colorado Springs, Colorado.; Saviano MS; Laboratory of Quantitative Neuromorphology, Neuroscience Program, Colorado College, Colorado Springs, Colorado.; Tummino TA; Laboratory of Quantitative Neuromorphology, Neuroscience Program, Colorado College, Colorado Springs, Colorado.; Bull AJ; Human Biology and Kinesiology, Colorado College, Colorado Springs, Colorado.; Driscoll LL; Laboratory of Quantitative Neuromorphology, Neuroscience Program, Colorado College, Colorado Springs, Colorado.; Raghanti MA; Department of Anthropology and School of Biomedical Sciences, Kent State University, Kent, Ohio.; Lewandowski AH; Cleveland Metroparks Zoo, Cleveland, Ohio.; Wicinski B; Fishberg Department of Neuroscience and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Ki Chui H; Laboratory of Quantitative Neuromorphology, Neuroscience Program, Colorado College, Colorado Springs, Colorado.; Bertelsen MF; Center for Zoo and Wild Animal Health, Copenhagen Zoo, Fredericksberg, Denmark.; Walsh T; Smithsonian National Zoological Park, Washington, District of Columbia.; Bhagwandin A; School of Anatomical Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Spocter MA; School of Anatomical Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Department of Anatomy, Des Moines University, Des Moines, Iowa.; Biomedical Sciences, College of Veterinary Medicine, Iowa State University, Ames, Iowa.; Hof PR; Fishberg Department of Neuroscience and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Sherwood CC; Department of Anthropology and Center for the Advanced Study of Human Paleobiology, The George Washington University, Washington, District of Columbia.; Manger PR; School of Anatomical Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0406041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-9861 (Electronic) Linking ISSN: 00219967 NLM ISO Abbreviation: J Comp Neurol Subsets: MEDLINE

O'Donnell HR; Department of Pharmaceutical Chemistry, University of California San Francisco (UCSF), San Francisco, California 94158-2550, United States.; Tummino TA; Department of Pharmaceutical Chemistry, University of California San Francisco (UCSF), San Francisco, California 94158-2550, United States.; Graduate Program in Pharmaceutical Sciences and Pharmacogenomics, UCSF, San Francisco, California 94158-2550, United States.; QBI COVID-19 Research Group (QCRG), San Francisco, California 94158-2550, United States.; Bardine C; Graduate Program in Chemistry & Chemical Biology, UCSF, San Francisco, California 94158-2550, United States.; Craik CS; Department of Pharmaceutical Chemistry, University of California San Francisco (UCSF), San Francisco, California 94158-2550, United States.; QBI COVID-19 Research Group (QCRG), San Francisco, California 94158-2550, United States.; Shoichet BK; Department of Pharmaceutical Chemistry, University of California San Francisco (UCSF), San Francisco, California 94158-2550, United States.; QBI COVID-19 Research Group (QCRG), San Francisco, California 94158-2550, United States.

Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem

Alon A; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.; Lyu J; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, USA.; Braz JM; Department of Anatomy, University of California, San Francisco, San Francisco, CA, USA.; Tummino TA; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, USA.; Graduate Program in Pharmaceutical Sciences and Pharmacogenomics, University of California, San Francisco, San Francisco, CA, USA.; Craik V; Department of Anatomy, University of California, San Francisco, San Francisco, CA, USA.; O'Meara MJ; Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA.; Webb CM; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, USA.; Graduate Program in Pharmaceutical Sciences and Pharmacogenomics, University of California, San Francisco, San Francisco, CA, USA.; Radchenko DS; Enamine, Kyiv, Ukraine.; Taras Shevchenko National University of Kyiv, Kyiv, Ukraine.; Moroz YS; Chemspace, Kyiv, Ukraine.; Huang XP; Department of Pharmacology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.; National Institute of Mental Health Psychoactive Drug Screening Program (NIMH PDSP), University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.; Liu Y; Department of Pharmacology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.; National Institute of Mental Health Psychoactive Drug Screening Program (NIMH PDSP), University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.; Roth BL; Department of Pharmacology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.; National Institute of Mental Health Psychoactive Drug Screening Program (NIMH PDSP), University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.; Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Irwin JJ; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, USA.; Basbaum AI; Department of Anatomy, University of California, San Francisco, San Francisco, CA, USA. Allan.Basbaum@ucsf.edu.; Shoichet BK; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, USA. shoichet@cgl.ucsf.edu.; Kruse AC; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA. Andrew_Kruse@hms.harvard.edu.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE

Oâ Donnell HR; Tummino TA; Bardine C; Craik CS; Shoichet BK

Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

Alon, Assaf; Lyu, Jiankun; Braz, Joao M; Tummino, Tia A; Craik, Veronica; O'Meara, Matthew J; Webb, Chase M.; Radchenko, Dmytro S; Moroz, Yurii S; Huang, Xi-Ping; Liu, Yongfeng; Roth, Bryan L; Irwin, John J; Basbaum, Allan I; Shoichet, Brian K; Kruse, Andrew C

Alon, Assaf, Jiankun Lyu, Joao M Braz, Tia A Tummino, Veronica Craik, Matthew J O'Meara, Chase M. Webb et al. "Structures of the σ2 receptor enable docking for bioactive ligand discovery." Nature 600, no. 7890 (2021): 759-764. DOI: 10.1038/s41586-021-04175-x

Tummino TA; Department of Pharmaceutical Chemistry, University of California San Francisco (UCSF), San Francisco, CA, USA.; Graduate Program in Pharmaceutical Sciences and Pharmacogenomics, UCSF, San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), UCSF, San Francisco, CA, USA.; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Rezelj VV; Institut Pasteur, Viral Populations and Pathogenesis Unit, CNRS UMR 3569, 75724 Paris, Cedex 15, France.; Fischer B; Novartis Institutes for BioMedical Research, Preclinical Safety, Basel, Switzerland.; Fischer A; Novartis Institutes for BioMedical Research, Preclinical Safety, Basel, Switzerland.; O'Meara MJ; Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA.; Monel B; Institut Pasteur, Virus and Immunity Unit, CNRS UMR 3569, 75724 Paris, Cedex 15, France.; Vallet T; Institut Pasteur, Viral Populations and Pathogenesis Unit, CNRS UMR 3569, 75724 Paris, Cedex 15, France.; Zhang Z; Quantitative Biosciences Institute (QBI), UCSF, San Francisco, CA, USA.; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, UCSF, San Francisco, CA, USA.; Howard Hughes Medical Institute, UCSF, San Francisco, CA, USA.; Alon A; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.; O'Donnell HR; Department of Pharmaceutical Chemistry, University of California San Francisco (UCSF), San Francisco, CA, USA.; Lyu J; Department of Pharmaceutical Chemistry, University of California San Francisco (UCSF), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), UCSF, San Francisco, CA, USA.; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Schadt H; Novartis Institutes for BioMedical Research, Preclinical Safety, Basel, Switzerland.; White KM; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Krogan NJ; Quantitative Biosciences Institute (QBI), UCSF, San Francisco, CA, USA.; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, UCSF, San Francisco, CA, USA.; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Gladstone Institute of Data Science and Biotechnology, J. David Gladstone Institutes, San Francisco, CA, USA.; Urban L; Novartis Institutes for BioMedical Research, Preclinical Safety, Cambridge, MA, USA.; Shokat KM; Quantitative Biosciences Institute (QBI), UCSF, San Francisco, CA, USA.; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, UCSF, San Francisco, CA, USA.; Howard Hughes Medical Institute, UCSF, San Francisco, CA, USA.; Kruse AC; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.; García-Sastre A; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Schwartz O; Institut Pasteur, Virus and Immunity Unit, CNRS UMR 3569, 75724 Paris, Cedex 15, France.; Moretti F; Novartis Institutes for BioMedical Research, Preclinical Safety, Basel, Switzerland.; Vignuzzi M; Institut Pasteur, Viral Populations and Pathogenesis Unit, CNRS UMR 3569, 75724 Paris, Cedex 15, France.; Pognan F; Novartis Institutes for BioMedical Research, Preclinical Safety, Basel, Switzerland.; Shoichet BK; Department of Pharmaceutical Chemistry, University of California San Francisco (UCSF), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), UCSF, San Francisco, CA, USA.; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.

Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

Gordon DE; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Jang GM; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Bouhaddou M; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Xu J; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Obernier K; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; White KM; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; O'Meara MJ; Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA.; Rezelj VV; Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France.; Guo JZ; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Swaney DL; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Tummino TA; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA.; Hüttenhain R; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Kaake RM; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Richards AL; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Tutuncuoglu B; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Foussard H; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Batra J; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Haas K; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Modak M; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Kim M; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Haas P; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Polacco BJ; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Braberg H; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Fabius JM; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Eckhardt M; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Soucheray M; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Bennett MJ; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Cakir M; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; McGregor MJ; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Li Q; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Meyer B; Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France.; Roesch F; Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France.; Vallet T; Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France.; Mac Kain A; Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France.; Miorin L; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Moreno E; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Naing ZZC; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Zhou Y; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Peng S; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA.; Shi Y; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Howard Hughes Medical Institute, University of California San Francisco, San Francisco, CA, USA.; Zhang Z; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Howard Hughes Medical Institute, University of California San Francisco, San Francisco, CA, USA.; Shen W; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Howard Hughes Medical Institute, University of California San Francisco, San Francisco, CA, USA.; Kirby IT; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Howard Hughes Medical Institute, University of California San Francisco, San Francisco, CA, USA.; Melnyk JE; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Howard Hughes Medical Institute, University of California San Francisco, San Francisco, CA, USA.; Chorba JS; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Howard Hughes Medical Institute, University of California San Francisco, San Francisco, CA, USA.; Lou K; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Howard Hughes Medical Institute, University of California San Francisco, San Francisco, CA, USA.; Dai SA; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Howard Hughes Medical Institute, University of California San Francisco, San Francisco, CA, USA.; Barrio-Hernandez I; European Molecular Biology Laboratory (EMBL), European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, UK.; Memon D; European Molecular Biology Laboratory (EMBL), European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, UK.; Hernandez-Armenta C; European Molecular Biology Laboratory (EMBL), European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, UK.; Lyu J; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA.; Mathy CJP; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA.; The UC Berkeley-UCSF Graduate Program in Bioengineering, University of California San Francisco, San Francisco, CA, USA.; Perica T; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA.; Pilla KB; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA.; Ganesan SJ; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA.; Saltzberg DJ; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA.; Rakesh R; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA.; Liu X; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA.; Rosenthal SB; Center for Computational Biology and Bioinformatics, Department of Medicine, University of California San Diego, San Diego, CA, USA.; Calviello L; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Department of Cell and Tissue Biology, University of California San Francisco, San Francisco, CA, USA.; Venkataramanan S; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Department of Cell and Tissue Biology, University of California San Francisco, San Francisco, CA, USA.; Liboy-Lugo J; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Department of Cell and Tissue Biology, University of California San Francisco, San Francisco, CA, USA.; Lin Y; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Department of Cell and Tissue Biology, University of California San Francisco, San Francisco, CA, USA.; Huang XP; Department of Pharmacology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.; Liu Y; Department of Pharmacology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.; Wankowicz SA; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA.; Biophysics Graduate Program, University of California San Francisco, San Francisco, CA, USA.; Bohn M; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA.; Safari M; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA, USA.; Ugur FS; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA.; Koh C; Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France.; Savar NS; Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France.; Tran QD; Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France.; Shengjuler D; Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France.; Fletcher SJ; Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France.; O'Neal MC; Zoic Labs, Culver City, CA, USA.; Cai Y; Zoic Labs, Culver City, CA, USA.; Chang JCJ; Zoic Labs, Culver City, CA, USA.; Broadhurst DJ; Zoic Labs, Culver City, CA, USA.; Klippsten S; Zoic Labs, Culver City, CA, USA.; Sharp PP; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Wenzell NA; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Kuzuoglu-Ozturk D; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.; Department of Urology, University of California San Francisco, San Francisco, CA, USA.; Wang HY; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Trenker R; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, USA.; Young JM; Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Cavero DA; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; George William Hooper Foundation, Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA.; Hiatt J; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Medical Scientist Training Program, University of California San Francisco, San Francisco, CA, USA.; Roth TL; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; George William Hooper Foundation, Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA.; Medical Scientist Training Program, University of California San Francisco, San Francisco, CA, USA.; Rathore U; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; George William Hooper Foundation, Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA.; Subramanian A; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; George William Hooper Foundation, Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA.; Noack J; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; George William Hooper Foundation, Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA.; Hubert M; Virus and Immunity Unit, Institut Pasteur, Paris, France.; Stroud RM; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA, USA.; Frankel AD; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA, USA.; Rosenberg OS; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA, USA.; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.; Verba KA; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA.; Agard DA; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA, USA.; Ott M; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.; Emerman M; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Jura N; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, USA.; von Zastrow M; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Department of Psychiatry, University of California San Francisco, San Francisco, CA, USA.; Verdin E; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.; Buck Institute for Research on Aging, Novato, CA, USA.; Ashworth A; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.; Schwartz O; Virus and Immunity Unit, Institut Pasteur, Paris, France.; d'Enfert C; Direction Scientifique, Institut Pasteur, Paris, France.; Mukherjee S; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; George William Hooper Foundation, Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA.; Jacobson M; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA.; Malik HS; Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Fujimori DG; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA.; Ideker T; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Division of Genetics, Department of Medicine, University of California San Diego, San Diego, CA, USA.; Craik CS; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.; Floor SN; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Department of Cell and Tissue Biology, University of California San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.; Fraser JS; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA.; Gross JD; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA.; Sali A; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA.; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA.; Roth BL; Department of Pharmacology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.; Ruggero D; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.; Department of Urology, University of California San Francisco, San Francisco, CA, USA.; Taunton J; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Kortemme T; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA.; The UC Berkeley-UCSF Graduate Program in Bioengineering, University of California San Francisco, San Francisco, CA, USA.; Beltrao P; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA.; European Molecular Biology Laboratory (EMBL), European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, UK.; Vignuzzi M; Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, Paris, France. marco.vignuzzi@pasteur.fr.; García-Sastre A; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Adolfo.Garcia-Sastre@mssm.edu.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Adolfo.Garcia-Sastre@mssm.edu.; Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Adolfo.Garcia-Sastre@mssm.edu.; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Adolfo.Garcia-Sastre@mssm.edu.; Shokat KM; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA. Kevan.Shokat@ucsf.edu.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA. Kevan.Shokat@ucsf.edu.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA. Kevan.Shokat@ucsf.edu.; Howard Hughes Medical Institute, University of California San Francisco, San Francisco, CA, USA. Kevan.Shokat@ucsf.edu.; Shoichet BK; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA. shoichet@cgl.ucsf.edu.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA. shoichet@cgl.ucsf.edu.; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA. shoichet@cgl.ucsf.edu.; Krogan NJ; QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA. nevan.krogan@ucsf.edu.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA. nevan.krogan@ucsf.edu.; J. David Gladstone Institutes, San Francisco, CA, USA. nevan.krogan@ucsf.edu.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA. nevan.krogan@ucsf.edu.; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. nevan.krogan@ucsf.edu.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE

Gordon DE; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; Jang GM; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; Bouhaddou M; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; Xu J; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; Obernier K; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; O'Meara MJ; Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, 48109, USA.; Guo JZ; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; Swaney DL; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; Tummino TA; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; Department of Pharmaceutical Chemistry, University of California, San Francisco.; Huettenhain R; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; Kaake RM; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; Richards AL; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; Tutuncuoglu B; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; Foussard H; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; Batra J; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; Haas K; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; Modak M; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; Kim M; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; Haas P; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; Polacco BJ; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; Braberg H; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; Fabius JM; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; Eckhardt M; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; Soucheray M; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; Bennett MJ; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; Cakir M; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; McGregor MJ; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; Li Q; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; Naing ZZC; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; Zhou Y; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; Peng S; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; Department of Pharmaceutical Chemistry, University of California, San Francisco.; Kirby IT; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; Howard Hughes Medical Institute.; Melnyk JE; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; Howard Hughes Medical Institute.; Chorba JS; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; Howard Hughes Medical Institute.; Lou K; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; Howard Hughes Medical Institute.; Dai SA; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; Howard Hughes Medical Institute.; Shen W; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; Howard Hughes Medical Institute.; Shi Y; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; Howard Hughes Medical Institute.; Zhang Z; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; Howard Hughes Medical Institute.; Barrio-Hernandez I; European Molecular Biology Laboratory (EMBL), European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.; Memon D; European Molecular Biology Laboratory (EMBL), European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.; Hernandez-Armenta C; European Molecular Biology Laboratory (EMBL), European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.; Mathy CJP; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco.; The UC Berkeley-UCSF Graduate Program in Bioengineering, University of California San Francisco, San Francisco, CA, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; Perica T; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco.; Pilla KB; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco.; Ganesan SJ; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco.; Saltzberg DJ; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco.; Ramachandran R; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco.; Liu X; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; Department of Pharmaceutical Chemistry, University of California, San Francisco.; Rosenthal SB; Center for Computational Biology and Bioinformatics, Department of Medicine, University of California San Diego.; Calviello L; Department of Cell and Tissue Biology, University of California, San Francisco.; Venkataramanan S; Department of Cell and Tissue Biology, University of California, San Francisco.; Liboy-Lugo J; Department of Cell and Tissue Biology, University of California, San Francisco.; Lin Y; Department of Cell and Tissue Biology, University of California, San Francisco.; Wankowicz SA; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; Biophysics Graduate Program, University of California, San Francisco.; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco.; Bohn M; Department of Pharmaceutical Chemistry, University of California, San Francisco.; Sharp PP; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; Trenker R; Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, 94158, USA.; Young JM; Division of Basic Sciences, Fred Hutchinson Cancer Research Center.; Cavero DA; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; Hiatt J; Medical Scientist Training Program, University of California, San Francisco, CA 94143, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; Roth TL; Medical Scientist Training Program, University of California, San Francisco, CA 94143, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; Rathore U; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; Subramanian A; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; George William Hooper Foundation, Department of Microbiology and Immunology, UC San Francisco.; Noack J; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; George William Hooper Foundation, Department of Microbiology and Immunology, UC San Francisco.; Hubert M; Virus and Immunity Unit, Institut Pasteur, 28 rue du Dr Roux, 75724 Paris Cedex 15, France.; Roesch F; Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, 28 rue du Dr Roux, 75724 Paris cedex 15, France.; Vallet T; Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, 28 rue du Dr Roux, 75724 Paris cedex 15, France.; Meyer B; Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, 28 rue du Dr Roux, 75724 Paris cedex 15, France.; White KM; Department for Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY.; Miorin L; Department for Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY.; Rosenberg OS; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.; Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA, USA.; Chan-Zuckerberg Biohub.; Verba KA; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; Department of Pharmaceutical Chemistry, University of California, San Francisco.; Agard D; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; Biochemistry & Biophysics and Quantitative Biosciences Institute UCSF 600 16th St San Francisco, CA 94143.; Ott M; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.; Emerman M; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98103.; Ruggero D; Department of Urology, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; García-Sastre A; Department for Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY.; Jura N; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; von Zastrow M; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; University of California San Francisco, Department of Psychiatry, San Francisco, CA, 94158, USA.; Taunton J; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; Ashworth A; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, 94158, USA.; Schwartz O; Virus and Immunity Unit, Institut Pasteur, 28 rue du Dr Roux, 75724 Paris Cedex 15, France.; Vignuzzi M; Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, 28 rue du Dr Roux, 75724 Paris cedex 15, France.; d'Enfert C; Direction Scientifique, Institut Pasteur, 28 rue du Dr Roux, 75724 Paris cedex 15, France.; Mukherjee S; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; George William Hooper Foundation, Department of Microbiology and Immunology, UC San Francisco.; Jacobson M; Department of Pharmaceutical Chemistry, University of California, San Francisco.; Malik HS; Division of Basic Sciences, Fred Hutchinson Cancer Research Center.; Fujimori DG; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; Department of Pharmaceutical Chemistry, University of California, San Francisco.; Ideker T; Division of Genetics, Department of Medicine, University of California San Diego.; Craik CS; Department of Pharmaceutical Chemistry, University of California, San Francisco.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, 94158, USA.; Floor S; Department of Cell and Tissue Biology, University of California, San Francisco.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, 94158, USA.; Fraser JS; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco.; Gross J; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; Department of Pharmaceutical Chemistry, University of California, San Francisco.; Sali A; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; Department of Pharmaceutical Chemistry, University of California, San Francisco.; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco.; Kortemme T; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco.; The UC Berkeley-UCSF Graduate Program in Bioengineering, University of California San Francisco, San Francisco, CA, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; Beltrao P; European Molecular Biology Laboratory (EMBL), European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.; Shokat K; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.; Howard Hughes Medical Institute.; Shoichet BK; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; Department of Pharmaceutical Chemistry, University of California, San Francisco.; Krogan NJ; QBI COVID-19 Research Group (QCRG), San Francisco, CA, 94158, USA.; University of California San Francisco, Quantitative Biosciences Institute (QBI), San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; University of California San Francisco, Department of Cellular and Molecular Pharmacology, San Francisco, CA, 94158, USA.

Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE